High Tide Closes Acquisition of a Majority Stake in Remexian Pharma GmbH
1. High Tide acquires a 51% interest in Remexian for €26.4 million. 2. Acquisition expands High Tide's footprint into Europe's regulated cannabis market. 3. Transaction represents a significant shift towards global cannabis operations. 4. Future options allow High Tide to acquire remaining 49% of Remexian. 5. High Tide's diversified revenue base strengthens its market position.